Video: Cubis® II Balance
13 June 2019 | By Sartorius AG
The new generation of modular premium laboratory balances.
List view / Grid view
13 June 2019 | By Sartorius AG
The new generation of modular premium laboratory balances.
For the past thirty years, native mass spectrometry has grown in both scope and reach in labs across the globe to encompass larger and more challenging molecular complexes. However, up until now, the throughput of these techniques has been slow and manual. Christopher Nortcliffe discusses ways that native analysis is…
All biological therapeutics have the potential to induce an immunemediated response ranging from benign to severe adverse effects.
A new AI project marks the first time 10 pharmaceutical companies have agreed to share data to aid drug discovery.
In this issue: novel approaches to produce radiolabelled antibodies, the use of CRISPR/Cas9 to accelerate the development of targeted therapies and utilisation of stem cells to study the effects of cannabis on neuronal development.
A new way to cleanly separate out cancer cells from a blood sample will enable comprehensive genetic profiling of the cancer cells.
Researchers have developed a new technology that allows them to probe cell changes without disturbing the cell’s physiology.
Today we are beginning to realise that lipids have been inadequately represented in biological and medical research. For decades, studies in the fields of DNA and proteins have been pushed but despite these adverse conditions, lipid research has made pioneering discoveries over the course of the last seven years. These…
A new study analysing both the entire set of genes and all the proteins produced by colon cancer tissues has revealed a more comprehensive view of the tumour.
New method for computational mass spectrometry will speed up the discovery of natural products that could be used in medicines...
Current technologies that measure molecular interactions for drug discovery slow down and complicate screening. Dianthus is the answer to the demands for fast, non-stop, highly sensitive hit identification, hit validation and lead optimisation.
A recently developed microfluidics device is able to detect and separate out cancer cells in blood, without the need for dilution...
A specific type of MRI, neuromelanin-sensitive magnetic resonance imaging, could lead to the measurement of a psychosis biomarker...
A blood test to measure pain has been developed, and could potentially aid physicians with more accuracy in diagnosis and prescriptions...